Oral Glucose Tolerance Test and Post Partum Diagnosis of Diabetes Mellitus, Type 2 (DT2 Post-Partum)
NCT ID: NCT03644004
Last Updated: 2019-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
173 participants
OBSERVATIONAL
2018-10-30
2019-02-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It diagnosis in risky subjects such as in patients with medical history of gestational diabetes is therefore imperative to prevent its complications.
Actual guidelines recommend an oral tolerance glucose test, measuring glucose levels after oral glucose intake (75g), between 6 an 12 weeks after childbirth. But studies reveal a low diagnosis rate.
The study of the current practices of diagnosis methods seem to be essential in order to improve this diagnosis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Abnormal Post-partum Glucose Metabolism After Gestational Diabetes Diagnosed Before or After 24 Weeks of Gestation
NCT01839448
Oral Glucose Tolerance Testing After Gestational Diabetes
NCT02082301
Is it Possible to Screen for Type 2 Diabetes at Day 2 in Gestational Diabetes Mellitus Patients Postpartum?
NCT00921882
Immediate Postpartum Glucose Tolerance Testing
NCT04199676
The Effect of Real-time Continuous Glucose Monitoring on Severe Complications to Pregnancy in Women With Diabetes
NCT00994357
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women with medical history of gestational diabetes
Patients followed at the hospital of Vienne for gestational diabetes in 2016.
frequency of diabetes mellitus, type 2, diagnosis in patients with medical history of gestational diabetes.
Patients will be contacted by mail with sending of the information notice to ask them to participate in the study.
If they don't reply, the subjects will be called by phone by the investigator to collect their non opposition of participation at the study.
During this call, the investigator will be able to answer all the questions about the study.
The report of this telephone conversation will be register in the medical file of the patient.
Then, we will collect informatic data from the hospital concerning the patients.
After that they will be contacted by phone to answer a survey. Beside, another secure survey will be send by email to each patient's family doctor.
To finish, crossing data between those of the patients and the family doctor and anonymisation of the data.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
frequency of diabetes mellitus, type 2, diagnosis in patients with medical history of gestational diabetes.
Patients will be contacted by mail with sending of the information notice to ask them to participate in the study.
If they don't reply, the subjects will be called by phone by the investigator to collect their non opposition of participation at the study.
During this call, the investigator will be able to answer all the questions about the study.
The report of this telephone conversation will be register in the medical file of the patient.
Then, we will collect informatic data from the hospital concerning the patients.
After that they will be contacted by phone to answer a survey. Beside, another secure survey will be send by email to each patient's family doctor.
To finish, crossing data between those of the patients and the family doctor and anonymisation of the data.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients who not speak french
* Patients who did not declared an attending physician
* Refusal to take part in the survey
* Patients lost to follow-up before childbirth
* Patients whose pregnancy ended by foetal death.
* Pre-existing diabet before pregnancy
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laura BOGENMANN, MD
Role: STUDY_DIRECTOR
Centre Hospitalier de Vienne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre hospitalier Lucien Hussel
Vienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL18_0210
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.